Correlation Between RenovoRx and Zura Bio
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Zura Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Zura Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Zura Bio Limited, you can compare the effects of market volatilities on RenovoRx and Zura Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Zura Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Zura Bio.
Diversification Opportunities for RenovoRx and Zura Bio
Very good diversification
The 3 months correlation between RenovoRx and Zura is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Zura Bio Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zura Bio Limited and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Zura Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zura Bio Limited has no effect on the direction of RenovoRx i.e., RenovoRx and Zura Bio go up and down completely randomly.
Pair Corralation between RenovoRx and Zura Bio
Given the investment horizon of 90 days RenovoRx is expected to generate 0.58 times more return on investment than Zura Bio. However, RenovoRx is 1.73 times less risky than Zura Bio. It trades about 0.42 of its potential returns per unit of risk. Zura Bio Limited is currently generating about -0.41 per unit of risk. If you would invest 98.00 in RenovoRx on August 27, 2024 and sell it today you would earn a total of 31.00 from holding RenovoRx or generate 31.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
RenovoRx vs. Zura Bio Limited
Performance |
Timeline |
RenovoRx |
Zura Bio Limited |
RenovoRx and Zura Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with RenovoRx and Zura Bio
The main advantage of trading using opposite RenovoRx and Zura Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Zura Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zura Bio will offset losses from the drop in Zura Bio's long position.RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals |
Zura Bio vs. Scandinavian Tobacco Group | Zura Bio vs. United Airlines Holdings | Zura Bio vs. Saia Inc | Zura Bio vs. Mesa Air Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |